Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.

Khorana AA, Soff GA, Kakkar AK, Vadhan-Raj S, Riess H, Wun T, Streiff MB, Garcia DA, Liebman HA, Belani CP, O'Reilly EM, Patel JN, Yimer HA, Wildgoose P, Burton P, Vijapurkar U, Kaul S, Eikelboom J, McBane R, Bauer KA, Kuderer NM, Lyman GH; CASSINI Investigators.

N Engl J Med. 2019 Feb 21;380(8):720-728. doi: 10.1056/NEJMoa1814630.

PMID:
30786186
2.

Reduction in Mortality following Elective Major Hip and Knee Surgery: A Systematic Review and Meta-Analysis.

Xu K, Chan NC, Ibrahim Q, Kruger P, Sinha S, Bhagirath V, Ginsberg J, Bangdiwala S, Guyatt G, Eikelboom J, Hirsh J.

Thromb Haemost. 2019 Apr;119(4):668-674. doi: 10.1055/s-0039-1677732. Epub 2019 Jan 30.

PMID:
30699447
3.

Rivaroxaban, Aspirin, or Both to Prevent Early Coronary Bypass Graft Occlusion: The COMPASS-CABG Study.

Lamy A, Eikelboom J, Sheth T, Connolly S, Bosch J, Fox KAA, Zhu J, Lonn E, Dagenais G, Widimsky P, Branch KRH, Bhatt DL, Zheng Z, Straka Z, Dagenais F, Kong Y, Marsden T, Lee SF, Copland I, Yusuf S.

J Am Coll Cardiol. 2019 Jan 22;73(2):121-130. doi: 10.1016/j.jacc.2018.10.048.

PMID:
30654882
4.

The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population.

Schiele F, Puymirat E, Ferrières J, Simon T, Fox KAA, Eikelboom J, Danchin N; FAST-MI investigators.

Int J Cardiol. 2019 Mar 1;278:7-13. doi: 10.1016/j.ijcard.2018.11.138. Epub 2018 Dec 3.

5.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
6.

Anticoagulant-Related Nephropathy.

Brodsky S, Eikelboom J, Hebert LA.

J Am Soc Nephrol. 2018 Dec;29(12):2787-2793. doi: 10.1681/ASN.2018070741. Epub 2018 Nov 12.

PMID:
30420420
7.

The association between blood donor sex and age and transfusion recipient mortality: an exploratory analysis.

Heddle NM, Cook RJ, Liu Y, Zeller M, Barty R, Acker JP, Eikelboom J, Arnold DM.

Transfusion. 2019 Feb;59(2):482-491. doi: 10.1111/trf.15011. Epub 2018 Nov 10.

PMID:
30414291
8.

Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.

Olesen KKW, Steensig K, Madsen M, Thim T, Jensen LO, Raungaard B, Eikelboom J, Kristensen SD, Bøtker HE, Maeng M.

Am J Cardiol. 2019 Jan 1;123(1):153-158. doi: 10.1016/j.amjcard.2018.09.011. Epub 2018 Sep 26.

PMID:
30389089
9.

Response to: Unacceptable conflicts of interest (Br J Anaesth 2018; 121: 1183).

Eikelboom J.

Br J Anaesth. 2018 Nov;121(5):1183-1184. doi: 10.1016/j.bja.2018.07.031. Epub 2018 Sep 6. No abstract available.

PMID:
30336866
10.

The Ross procedure versus prosthetic and homograft aortic valve replacement: a systematic review and meta-analysis.

McClure GR, Belley-Cote EP, Um K, Gupta S, Bouhout I, Lortie H, Alraddadi H, Alsagheir A, McIntyre WF, Dorobantu DM, Bossard M, Kim K, Stoica S, Eikelboom J, Ouzounian M, Chu MWA, Parry D, El-Hamamsy I, Whitlock RP.

Eur J Cardiothorac Surg. 2019 Feb 1;55(2):247-255. doi: 10.1093/ejcts/ezy247.

PMID:
30084899
11.

Is there a role for pharmacokinetic/pharmacodynamic-guided dosing for novel oral anticoagulants?

Chan N, Sager PT, Lawrence J, Ortel T, Reilly P, Berkowitz S, Kubitza D, Eikelboom J, Florian J, Stockbridge N, Rose M, Temple R, Seltzer JH.

Am Heart J. 2018 May;199:59-67. doi: 10.1016/j.ahj.2017.10.002. Epub 2017 Oct 10. Review.

PMID:
29754667
12.

International Normalized Ratio Targets for Left-Sided Mechanical Valve Replacement.

Gupta S, Belley-Cote EP, Sarkaria A, Pandey A, Spence J, McClure G, Panchal P, Jaffer IH, An K, Eikelboom J, Whitlock RP.

Thromb Haemost. 2018 May;118(5):906-913. doi: 10.1055/s-0038-1637755. Epub 2018 Apr 3.

PMID:
29614524
13.

Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation.

Bassand JP, Accetta G, Al Mahmeed W, Corbalan R, Eikelboom J, Fitzmaurice DA, Fox KAA, Gao H, Goldhaber SZ, Goto S, Haas S, Kayani G, Pieper K, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK; GARFIELD-AF Investigators.

PLoS One. 2018 Jan 25;13(1):e0191592. doi: 10.1371/journal.pone.0191592. eCollection 2018.

14.

Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.

Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK; GARFIELD-AF Investigators.

Eur Heart J. 2018 Feb 7;39(6):464-473. doi: 10.1093/eurheartj/ehx730.

PMID:
29281086
15.

HERDOO2 identified women at low risk for recurrence after 5 to 12 mo of anticoagulation for a first unprovoked VTE.

Kruger P, Eikelboom J.

Ann Intern Med. 2017 Sep 19;167(6):JC33. doi: 10.7326/ACPJC-2017-167-6-033. No abstract available.

PMID:
28975323
16.

Rivaroxaban for Preventing Venous Thromboembolism in High-Risk Ambulatory Patients with Cancer: Rationale and Design of the CASSINI Trial. Rationale and Design of the CASSINI Trial.

Khorana AA, Vadhan-Raj S, Kuderer NM, Wun T, Liebman H, Soff G, Belani C, O'Reilly EM, McBane R, Eikelboom J, Damaraju CV, Beyers K, Dietrich F, Kakkar AK, Riess H, Peixoto RD, Lyman GH.

Thromb Haemost. 2017 Nov 1;117(11):2135-2145. doi: 10.1160/TH17-03-0171. Epub 2017 Sep 21.

17.

Resuming warfarin after intracranial hemorrhage in patients with AF was linked to reduced mortality.

Kruger P, Eikelboom J.

Ann Intern Med. 2017 Jun 20;166(12):JC70. doi: 10.7326/ACPJC-2017-166-12-070. No abstract available.

PMID:
28630982
18.

Bleeding with direct oral anticoagulants vs warfarin: clinical experience.

Eikelboom J, Merli G.

Am J Emerg Med. 2016 Nov;34(11S):3-8. doi: 10.1016/j.ajem.2016.09.046. Epub 2016 Sep 29. Review.

19.

Corrigendum to "Dabigatran in clinical practice: Contemporary overview of the evidence" [Int. J. Cardiol. 220 (2016) 417-428].

Ageno W, Eikelboom J, Lip GY.

Int J Cardiol. 2016 Nov 15;223:1074-1076. doi: 10.1016/j.ijcard.2016.08.332. Epub 2016 Sep 7. No abstract available.

PMID:
27614571
20.

Bleeding with Direct Oral Anticoagulants vs Warfarin: Clinical Experience.

Eikelboom J, Merli G.

Am J Med. 2016 Nov;129(11S):S33-S40. doi: 10.1016/j.amjmed.2016.06.003. Epub 2016 Aug 30. Review.

Supplemental Content

Loading ...
Support Center